Clinical Trials · NCT05473286
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
- Phase
- N/A
- Recruitment status
- Withdrawn
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 0
- Start date
- Sep 2022
- Locations
- See registry
- Primary endpoint
- Change in Glycated haemoglobin (HbA1c )